{"pub_date": "2016-03-01T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "Even if the drug maker\u2019s delayed 2015 earnings are published soon, J. Michael Pearson\u2019s room for maneuvering is shrinking.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "CYRAN", "firstname": "Robert", "role": "reported"}], "original": "By ROBERT CYRAN"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 395, "url": "images/2016/02/29/business/29valeant-web/29valeant-web-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "395", "xlarge": "images/2016/02/29/business/29valeant-web/29valeant-web-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"content_kicker": "Breakingviews", "main": "Valeant Chief Returns to a Difficult To-Do List", "kicker": "Breakingviews"}, "source": "The New York Times", "blog": [], "word_count": "371", "web_url": "http://www.nytimes.com/2016/03/01/business/dealbook/valeant-chief-returns-to-a-difficult-to-do-list.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Even if the drug maker\u2019s delayed 2015 earnings are published soon, J. Michael Pearson\u2019s room for maneuvering is shrinking.", "_id": "56d4bb2c38f0d811294b8142", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N"}, {"rank": "3", "name": "organizations", "value": "Actavis PLC", "is_major": "N"}, {"rank": "4", "name": "organizations", "value": "Salix Pharmaceuticals Ltd", "is_major": "N"}, {"rank": "5", "name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N"}]}